Tuberculosis Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

What are the features of TB disease?

A
  • Common as chronic pneumonia
  • Caused by Mycobacterium tuberculosis
  • Can affect sites other than lungs
  • Deceptive onset
  • Persistent productive cough
  • Fever, night sweats, weight loss
  • Lungs most commonly infected (pulmonary TB)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What’s the difference between TB infection and TB disease?

A

• Infection/Latent TB

o Immune system controls disease

• Disease/Symptoms of TB

o Bacteria escapes immune response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the significance of TB?

A
  • 2nd most common single infectious cause of death (first= HIV)
  • 1/3 world infected
  • 1.4 million deaths 2010
  • Multidrug resistance (1st line drugs: INH, RIF and additional drugs)and completely drug resistant strains
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What issues arise for AIDs patients when it comes to TB?

A

• Co-infections HIV and M. tuberculosis big issue (developing countries)

o Reactivate latent infection, rapid progression of new infection

  • AIDs patients likely to get disseminated disease (lack of CD4 T cells/cell mediated immunity)
  • AIDs patients susceptible to opportunistic infection (MAC)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is MAC?

A
  • MAC = mycobacterium avium complex
  • From the environment (water, soil), colonises GIT and invades deeper tissue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the characteristic of mycobacteria?

A
  • Often environmental, harmless species
  • Pathogens = M. tuberculosis, MAC, M. Bovis
  • Cell wall prevents gram staining
  • Cell wall acid fast
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the features of M. tuberculosis as bacteria?

A
  • Obligate aerobe
  • Acid fast
  • Resistant to drying
  • But sensitive to heat
  • Grows very slow (use diagnostics other than culture, long time to determine antimicrobial susceptibility and treat)
  • Survive in host macrophages
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is special about mycobacteria cell walls?

A
  • Cell wall acid fast
  • Other molecules outside peptidoglycan layer
  • Lipo-arabinomannam: superficial lipids, mycolic acids, arabinogalactam
  • Extra cell wall components can help modulate host immune response
  • Retain basic dye
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does acid fast mean? What staining procedures are used for these organisms?

A
  • Retain basic dye
  • Ziel Neilsen stain
    1. Use strong basic dye and apply with heat (10mins)-everything pink
    1. Decolourise smear with acid alcohol- goes colourless but mycobacteria bacilli retain pink dye
    1. Counterstain with blue dye to stain everything else on slide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How can TB be transmitted?

A

• Inhale nuclei droplets from aerosols

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What sizes of droplet nuclei are most efficient for spreading TB? Why?

A
  • Ideal to be <5microns because stay suspended longer and penetrate into alveoli
  • If larger than 5 microns, settle rapidly or removed by cilia and mucus
  • Evade mucociliary elevator of large airways, enter alveoli, enter macrophages
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What usually happens when LRT pathogens interact with the innate immune system?

A
  • Microbes access lungs, alveolar macrophages
  • Bind multiple receptors, activate bactericidal processes
  • Cytokines, chemokines
  • Microbe removed, adaptive system may help
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What happens when M. tuberculosis interacts with the innate immune system?

A
  • Inhale nuclei droplet
  • Go to alveolar macrophages
  • Binding to receptors = poor activation of phagosome maturation and bactericidal processes
  • Lysosome fusion inhibited by lipids on mycobacteria
  • Phagosome pH maintained, bacteria can replicate inside
  • Limited degradation, but enough to activate CD4 T cells
  • Macrophage release (symptoms)

o IL-1

o IL-8

o IL 12 – TH1 cells induced

o TNF α

• Mycobacterium survive and replicates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What occurs in the lymphoid tissue due to M. tuberculosis?

A
  • APCS display M. tuberculosis peptides, induce TH1 (IL-12) cells to secret IFNγ
  • Macrophages are activated and results in inflammation and tissue damage
  • TH17 induced too for neutrophil recruitment (but neutrophils can’t kill)
  • Mycobacterium resistant to macrophage killing so TH1 and TH17 cells continuously made
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the cycle that occurs following inhalation of TB?

A
    1. Inhale TB laden droplet nuclei
    1. Multiplication in alveolar macrophages
    1. Cytokine and chemokine production, monocyte influx, limited degradation
    1. Macrophage and DC migrate to hilar LN, present mycobacteria antigens to T cells
    1. T cell activation
    1. Activated CD8, TH1, CD4, other IFNγ secreting cells migrate to infection site and further activate infected macrophages, recruit neutrophils (back to step 3)
    1. Mycobacteria persist – prolonged infection

o Delayed type hypersensitivity and granuloma formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What occurs due to IFNγ activation of macrophages?

A
  • IFNγ activate macrophage, produce IL-1, IL-8, TNFα (activate endothelium, phagocytes and lymphocytes migrate from circulation)
  • More IL-1 (fever)
  • More TNFα (weight loss, granuloma formation, death of some infected macrophages)
  • GRANULOMA
17
Q

What makes up a granuloma?

A
  • Accumulation of multinucleate giant cell (macrophages fuse), surrounded by epitheliod cells, surrounded by T lymphocytes
  • Contains organism in 90% infections
18
Q

What are the features of latent TB?

A
  • 90% of infected have controlled infection due to delayed type hypersensitivity response
  • No symptoms and non-infectious
19
Q

What are primary and secondary TB? What increases the risk of getting these?

A

• Primary TB

o 5% patients don’t control initial infection

o Worsening pneumonia

o Possible dissemination to other organs

• Secondary TB

o Infection controlled by 5-10% have reactivation of latent disease

• Compromised immune system more susceptible to primary or secondary TB

20
Q

How does secondary TB arise?

A

• Reactivation commonly in lung (bacteria replicate there)

o Caseous necrosis

o Cavity formation

  • Granulomas enlarge, increased immune response, excess cytokines, tissue damage, TB symptoms
  • Lots of sputum with acid fast bacilli
  • Contagious patient
21
Q

How can we screen for M. tuberculosis? What are the features of the processes?

A
  • Doesn’t indicate immunity or disease
  • Tuberculin Skin Test/Mantoux Test

o Inject purified protein derivative (PPD) (tuberculin)

o Memory T cells migrate to injection site, induce inflammation, show delayed hypersensitivity reaction

• Interferon production in response to in vitro stimulation with specific TB antigens (IGRA)

o Collect blood and add to culture medium o Add antigens

o Incubate

o Test for IFNγ secreted into medium by activated memory T cells activated by the PPD

22
Q

How can active TB disease be diagnosed in the lab?

A
  • X ray
  • Acid fast bacilli
  • Culture on enriched medium

o Solid 4-8 weeks

o Specialised liquid 7-14 days

  • Unreliable antibody detection
  • New nucleic acid tests

o Cartridge based automated

o PCR and identifies m. tuberculosis DNA (presence) and resistance to Rifampicin

23
Q

What is short course therapy? What kind of TB disease is it used for?

A
  • For active disease
  • 6 months
  • First Line:

o Rifampicin

o Isoniazid (INH)

o Pyrazinamide (PZA)

o Ethambutol

o RIPE

• All four for 2 months then R and I for 4months

24
Q

What is special about INH and PZA?

A
  • INH and PZA = pro-drugs
  • Activated by mycobacterial enzymes (KatG, Pyrazinamidase)
25
Q

How can latent TB be treated?

A
  • If positive and no evidence of active diseases: recently infected or latent disease
  • Use INH to reduce reactivation
  • Chemoprophylaxis of latent TB reduced incidence of progression to active disease
26
Q

What are the features of the TB vaccine?

A
  • Long term M. bovis culture
  • 100% conversion to tuberculin positive in vaccinees
  • Variable protection
  • Live attenuated dangerous if immunocompromised
  • Current recommendation- use BCG where TB incidence high or in young